Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

High-level expression and immunogenicity of a porcine circovirus type 2 capsid protein through codon optimization in Pichia pastoris.

Tu Y, Wang Y, Wang G, Wu J, Liu Y, Wang S, Jiang C, Cai X.

Appl Microbiol Biotechnol. 2013 Apr;97(7):2867-75. doi: 10.1007/s00253-012-4540-z. Epub 2012 Nov 10.

PMID:
23143467
2.

Secretory expression of Porcine Circovirus Type 2 capsid protein in Pichia pastoris.

Silva JG, Coimbra EC, Jesus AL, Mariz FC, Silva KM, Lobato ZI, Campos AC, Coutinho LC, Castro RS, Freitas AC.

J Virol Methods. 2014 Oct;207:226-31. doi: 10.1016/j.jviromet.2014.07.021. Epub 2014 Jul 24.

PMID:
25066279
3.

The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.

Bucarey SA, Noriega J, Reyes P, Tapia C, Sáenz L, Zuñiga A, Tobar JA.

Vaccine. 2009 Sep 25;27(42):5781-90. doi: 10.1016/j.vaccine.2009.07.061. Epub 2009 Aug 5.

PMID:
19664739
4.

Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus.

Liu LJ, Suzuki T, Tsunemitsu H, Kataoka M, Ngata N, Takeda N, Wakita T, Miyamura T, Li TC.

Arch Virol. 2008;153(12):2291-5. doi: 10.1007/s00705-008-0248-x. Epub 2008 Nov 9.

PMID:
18998045
5.

High-level expression, purification, and enzymatic characterization of truncated poly(vinyl alcohol) dehydrogenase in methylotrophic yeast Pichia pastoris.

Jia D, Li J, Liu L, Zhang D, Yang Y, Du G, Chen J.

Appl Microbiol Biotechnol. 2013 Feb;97(3):1113-20. doi: 10.1007/s00253-012-3986-3. Epub 2012 Mar 10.

PMID:
22406863
6.

A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.

Zhang H, Qian P, Peng B, Shi L, Chen H, Li X.

Vaccine. 2015 May 15;33(21):2449-56. doi: 10.1016/j.vaccine.2015.03.090. Epub 2015 Apr 8.

PMID:
25863115
7.

Heterologous expression of full-length capsid protein of porcine circovirus 2 in Escherichia coli and its potential use for detection of antibodies.

Marcekova Z, Psikal I, Kosinova E, Benada O, Sebo P, Bumba L.

J Virol Methods. 2009 Dec;162(1-2):133-41. doi: 10.1016/j.jviromet.2009.07.028. Epub 2009 Aug 5.

PMID:
19664658
8.

Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.

Sylla S, Cong YL, Sun YX, Yang GL, Ding XM, Yang ZQ, Zhou YL, Yang M, Wang CF, Ding Z.

Microbiol Immunol. 2014 Jul;58(7):398-408. doi: 10.1111/1348-0421.12158.

9.

Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.

Wu PC, Lin WL, Wu CM, Chi JN, Chien MS, Huang C.

Appl Microbiol Biotechnol. 2012 Sep;95(6):1501-7. doi: 10.1007/s00253-012-4015-2. Epub 2012 Apr 12.

PMID:
22526782
10.

Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice.

Wang X, Jiang W, Jiang P, Li Y, Feng Z, Xu J.

Vaccine. 2006 Apr 12;24(16):3374-80. Epub 2006 Feb 23.

PMID:
16524646
11.

Secreted expression of truncated capsid protein from porcine circovirus type 2 in Pichia pastoris.

Chen X, Chen J, Zhang Y, Zhu P, Deng Y, Liu Q.

Biotechnol Lett. 2016 Jun;38(6):959-67. doi: 10.1007/s10529-016-2076-5. Epub 2016 Mar 19.

PMID:
26994771
12.

Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice.

Fan H, Pan Y, Fang L, Wang D, Wang S, Jiang Y, Chen H, Xiao S.

J Virol Methods. 2008 Jun;150(1-2):21-6. doi: 10.1016/j.jviromet.2008.02.011. Epub 2008 Apr 3.

PMID:
18394722
13.

Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.

Wang YP, Liu D, Guo LJ, Tang QH, Wei YW, Wu HL, Liu JB, Li SB, Huang LP, Liu CM.

Vaccine. 2013 Jan 21;31(5):833-8. doi: 10.1016/j.vaccine.2012.11.062. Epub 2012 Dec 3.

PMID:
23219694
15.
16.

Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2.

Lin HX, Ma Z, Fan HJ, Lu CP.

Vaccine. 2012 Sep 28;30(44):6307-13. doi: 10.1016/j.vaccine.2012.07.082. Epub 2012 Aug 8.

PMID:
22884664
17.

Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.

Wu PC, Chen TY, Chi JN, Chien MS, Huang C.

J Biotechnol. 2016 Feb 20;220:78-85. doi: 10.1016/j.jbiotec.2016.01.017. Epub 2016 Jan 18.

PMID:
26795354
18.

Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.

Wang Y, Lu Y, Liu D, Wei Y, Guo L, Wu H, Huang L, Liu J, Liu C.

Appl Microbiol Biotechnol. 2015 Feb;99(3):1155-63. doi: 10.1007/s00253-014-6167-8. Epub 2014 Dec 9.

PMID:
25487886
19.

Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments.

Fan H, Xiao S, Tong T, Wang S, Xie L, Jiang Y, Chen H, Fang L.

Mol Immunol. 2008 Feb;45(3):653-60. Epub 2007 Aug 20.

PMID:
17709139
20.

Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis.

Li PC, Qiao XW, Zheng QS, Hou JB.

Vaccine. 2016 Jan 27;34(5):696-702. doi: 10.1016/j.vaccine.2015.09.007. Epub 2015 Sep 13.

PMID:
26372858

Supplemental Content

Support Center